The effect of probiotics versus Goreisan in adults with acute infectious gastroenteritis: A randomized controlled trial.

The effect of probiotics versus Goreisan in adults with acute infectious gastroenteritis: A randomized controlled trial. - The effect of probiotics versus Goreisan in adults with acute infectious gastroenteritis: A randomized controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015875

Enrollment

200

Registered

2014-12-12

Start date

2014-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute infectious gastroenteritis

Interventions

Goreisan (Tsumura &amp

Co.) 7.5g per day three times a day for 5 days LAC-B granular powder N (Kowa Co.) 3g per day three times a day for 5 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility criteria are an age of 20 years and older, a symptom of diarrhea or vomiting, a diagnosis of acute infectious gastroenteritis by a physician.

Exclusion criteria

Exclusion criteria: Under 20 years old An inability to obtain informed consent Patients with gastrointestinal tract problems (e.g colon cancer, inflammatory bowel disease) Patients who need antibiotics for treatment Pregnant or suspicion of being pregnant Female with brest feeding Patients with known severe liver dysfunction

Design outcomes

Primary

Measure	Time frame
Time to improve diarrhea and loose stools Time to improve nausea and vomiting The total number of diarrhea The total number of vomiting	—

Countries

Japan

Contacts

Public ContactFujiko Morita

Juntendo university school of medicine Department of General Medicine

f-morita@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026